Virpax Pharmaceuticals, Inc

We are focused on becoming a global leader in promoting and marketing branded non-addictive pain management pharmaceutical products.

  • Stage Product In Development
  • Industry Other
  • Location Berwyn, PA, USA
  • Currency USD
  • Founded May 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website virpaxpharma.com

Company Summary

We will enter the prescription analgesic/pain market with its lead product, DSF100, a novel NSAID topical spray film. We have exclusive rights to the Spray Film for use with its NSAID- based product candidate and plans to negotiate for the rights to apply this technology to range of additional product candidates to build a portfolio using this transdermal film delivery system with non-opioid molecules to treat acute an chronic pain conditions.

Team

  • Anthony Mack

  • Anthony Mack
    President and CEO

    20+ years exp. pharma and finance industries. Founder & Exec Officer Scilex Pharma & ProSolus Pharma a R&D & cGMP transdermal manufacturing facility. Agreements with US and international pharma partners to develop generic transdermal prescriptions. High-level positions Purdue, Endo, Novartis & EKR Therapeutics. Led marketing & commercial distrib. for $billion pain mgmt prods. Exec MBA - Pharmaceutical & Healthcare Marketing - St Joseph’s Univ.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free